Geert Jan Groeneveld

Geert Jan Groeneveld is currently the CEO, Chief Scientific Officer, and Chief Medical Officer at the Centre for Human Drug Research. Geert Jan is also a Professor of Clinical Neuropharmacology at Leiden University Medical Center and has previously worked as a Neurologist at VUmc. With a background in medicine and global management, Groeneveld has extensive experience in conducting clinical drug studies in neurology and pain. Geert Jan has also made significant contributions to clinical research, particularly in the field of neurology, Parkinson's Disease, and Pompe disease.